Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Collplant Biotechnologies Ltd

Collplant Biotechnologies Ltd

CLGN · NASDAQ
CLGN · NASDAQ

Next Earnings: 27 May 2025

3.91
USD-0.18-4.30%

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

3.91USD
4.05USD

52 Week Range

3.31USD
6.99USD

Market Cap

46.8MUSD

About

General Information

Type

Common Stock

Exchange

NASDAQ

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

IL0004960188

CUSIP

19516R107

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

2.48

Dividend Share

-

Dividend Yield

-

Earnings Share

-1.53

Wall Street Target Price

12.5

EPS Estimate Current Year

0

EPS Estimate Next Year

0

EPS Estimate Current Quarter

0

EPS Estimate Next Quarter

0

Most Recent Quarter

-

Profitability

Revenue TTM

689,000

Gross Profit TTM

13,636,000

EBITDA

-17,308,000

Profit Margin

0.00%

Return On Assets TTM

-33.77%

Return On Equity TTM

-61.55%

Revenue Per Share TTM

0.06

Qtly Revenue Growth YOY

-97.60%

Diluted Eps TTM

-1.53

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

15

Price Sales TTM

65.003

Price Book MRQ

2.7663

Enterprise Value Revenue

53

Enterprise Value EBITDA

-5

Peers analysis

  • CSL Limited
    CMXHFCSL Limited

    178.29

    4.66%
  • BioNTech SE
    BNTXBioNTech SE

    119.36

    2.26%
  • Vertex Pharmaceuticals Inc
    VRTXVertex Pharmaceuticals Inc

    472.25

    0.57%
  • Alnylam Pharmaceuticals Inc
    ALNYAlnylam Pharmaceuticals Inc

    255.10

    0.52%
  • BeiGene Ltd
    BGNEBeiGene Ltd

    188.00

    0.27%
  • Regeneron Pharmaceuticals Inc
    REGNRegeneron Pharmaceuticals Inc

    778.55

    0.01%
  • argenx SE
    ARGNFargenx SE

    525.60

    0.00%
  • UCB SA ADR
    UCBJYUCB SA ADR

    94.73

    -1.46%
  • CSL Ltd
    CSLLYCSL Ltd

    89.92

    -0.81%
  • argenx NV ADR
    ARGXargenx NV ADR

    609.88

    -0.50%